Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 224 entries
Sorted by: Best Match Show Resources per page
Early and late effects of prenatal corticosteroid treatment on the microRNA profiles of lung tissue in rats.

Experimental and therapeutic medicine

Yu HR, Li SC, Tseng WN, Tain YL, Chen CC, Sheen JM, Tiao MM, Kuo HC, Huang CC, Hsieh KS, Huang LT.
PMID: 26997989
Exp Ther Med. 2016 Mar;11(3):753-762. doi: 10.3892/etm.2016.2992. Epub 2016 Jan 13.

Glucocorticoids have been administered to mothers at risk of premature delivery to induce maturation of preterm fetal lungs and prevent the development of respiratory distress syndrome. Micro (mi)RNAs serve various crucial functions in cell proliferation, differentiation and organ development;...

Cite
Yu HR, Li SC, Tseng WN, et al. Early and late effects of prenatal corticosteroid treatment on the microRNA profiles of lung tissue in rats. Exp Ther Med. 2016;11(3):753-762doi: 10.3892/etm.2016.2992.
Yu, H. R., Li, S. C., Tseng, W. N., Tain, Y. L., Chen, C. C., Sheen, J. M., Tiao, M. M., Kuo, H. C., Huang, C. C., Hsieh, K. S., & Huang, L. T. (2016). Early and late effects of prenatal corticosteroid treatment on the microRNA profiles of lung tissue in rats. Experimental and therapeutic medicine, 11(3), 753-762. https://doi.org/10.3892/etm.2016.2992
Yu, Hong-Ren, et al. "Early and late effects of prenatal corticosteroid treatment on the microRNA profiles of lung tissue in rats." Experimental and therapeutic medicine vol. 11,3 (2016): 753-762. doi: https://doi.org/10.3892/etm.2016.2992
Yu HR, Li SC, Tseng WN, Tain YL, Chen CC, Sheen JM, Tiao MM, Kuo HC, Huang CC, Hsieh KS, Huang LT. Early and late effects of prenatal corticosteroid treatment on the microRNA profiles of lung tissue in rats. Exp Ther Med. 2016 Mar;11(3):753-762. doi: 10.3892/etm.2016.2992. Epub 2016 Jan 13. PMID: 26997989; PMCID: PMC4774352.
Copy Download .nbib Format: NLM
The Comparison of Outcome between Thromboaspiration and Aggressive Mechanical Clot Disruption in Treating Hyperacute Stroke Patients.

Journal of Korean Neurosurgical Society

Lee HG, Rhim JK, Kim YH, Sheen SH, Oh SH, Chung BS.
PMID: 22200012
J Korean Neurosurg Soc. 2011 Oct;50(4):311-6. doi: 10.3340/jkns.2011.50.4.311. Epub 2011 Oct 31.

OBJECTIVE: Stroke is the third leading cause of death in the Republic of Korea. Time is the most important factor in hyperacute stroke. Yet, there had been no protocol for mechanical thrombolysis. We have treated patients with hyperacute stroke...

Cite
Lee HG, Rhim JK, Kim YH, et al. The Comparison of Outcome between Thromboaspiration and Aggressive Mechanical Clot Disruption in Treating Hyperacute Stroke Patients. J Korean Neurosurg Soc. 2011;50(4):311-6doi: 10.3340/jkns.2011.50.4.311.
Lee, H. G., Rhim, J. K., Kim, Y. H., Sheen, S. H., Oh, S. H., & Chung, B. S. (2011). The Comparison of Outcome between Thromboaspiration and Aggressive Mechanical Clot Disruption in Treating Hyperacute Stroke Patients. Journal of Korean Neurosurgical Society, 50(4), 311-6. https://doi.org/10.3340/jkns.2011.50.4.311
Lee, Hyun Goo, et al. "The Comparison of Outcome between Thromboaspiration and Aggressive Mechanical Clot Disruption in Treating Hyperacute Stroke Patients." Journal of Korean Neurosurgical Society vol. 50,4 (2011): 311-6. doi: https://doi.org/10.3340/jkns.2011.50.4.311
Lee HG, Rhim JK, Kim YH, Sheen SH, Oh SH, Chung BS. The Comparison of Outcome between Thromboaspiration and Aggressive Mechanical Clot Disruption in Treating Hyperacute Stroke Patients. J Korean Neurosurg Soc. 2011 Oct;50(4):311-6. doi: 10.3340/jkns.2011.50.4.311. Epub 2011 Oct 31. PMID: 22200012; PMCID: PMC3243833.
Copy Download .nbib Format: NLM
Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches.

World journal of transplantation

Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A.
PMID: 32226769
World J Transplant. 2020 Feb 28;10(2):29-46. doi: 10.5500/wjt.v10.i2.29.

Transplant recipients are vulnerable to a higher risk of malignancy after solid organ transplantation and allogeneic hematopoietic stem-cell transplant. Post-transplant lymphoproliferative disorders (PTLD) include a wide spectrum of diseases ranging from benign proliferation of lymphoid tissues to frank malignancy...

Cite
Abbas F, El Kossi M, Shaheen IS, et al. Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches. World J Transplant. 2020;10(2):29-46doi: 10.5500/wjt.v10.i2.29.
Abbas, F., El Kossi, M., Shaheen, I. S., Sharma, A., & Halawa, A. (2020). Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches. World journal of transplantation, 10(2), 29-46. https://doi.org/10.5500/wjt.v10.i2.29
Abbas, Fedaey, et al. "Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches." World journal of transplantation vol. 10,2 (2020): 29-46. doi: https://doi.org/10.5500/wjt.v10.i2.29
Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A. Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches. World J Transplant. 2020 Feb 28;10(2):29-46. doi: 10.5500/wjt.v10.i2.29. PMID: 32226769; PMCID: PMC7093305.
Copy Download .nbib Format: NLM
Differences in Vancomycin Clearance between Trauma and Medical Intensive Care Unit Patients.

Infection & chemotherapy

Cho H, Lee S, Sheen S, Choi YH.
PMID: 31997602
Infect Chemother. 2020 Mar;52(1):48-58. doi: 10.3947/ic.2020.52.1.48. Epub 2020 Jan 21.

BACKGROUND: To identify the differences in the vancomycin pharmacokinetics between multiple trauma patients and medically ill patients in the intensive care unit (ICU) stratified by the use of continuous renal replacement therapy (CRRT), and the factors affecting vancomycin clearance...

Cite
Cho H, Lee S, Sheen S, et al. Differences in Vancomycin Clearance between Trauma and Medical Intensive Care Unit Patients. Infect Chemother. 2020;52(1):48-58doi: 10.3947/ic.2020.52.1.48.
Cho, H., Lee, S., Sheen, S., & Choi, Y. H. (2020). Differences in Vancomycin Clearance between Trauma and Medical Intensive Care Unit Patients. Infection & chemotherapy, 52(1), 48-58. https://doi.org/10.3947/ic.2020.52.1.48
Cho, Hundo, et al. "Differences in Vancomycin Clearance between Trauma and Medical Intensive Care Unit Patients." Infection & chemotherapy vol. 52,1 (2020): 48-58. doi: https://doi.org/10.3947/ic.2020.52.1.48
Cho H, Lee S, Sheen S, Choi YH. Differences in Vancomycin Clearance between Trauma and Medical Intensive Care Unit Patients. Infect Chemother. 2020 Mar;52(1):48-58. doi: 10.3947/ic.2020.52.1.48. Epub 2020 Jan 21. PMID: 31997602; PMCID: PMC7113446.
Copy Download .nbib Format: NLM
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan.

Scientific reports

Yang YL, Jaing TH, Chen SH, Liu HC, Hung IJ, Lin DT, Yang CP, Peng CT, Lin KH, Hsiao CC, Jou ST, Chen JS, Lin MT, Wang SC, Chang TK, Huang FL, Cheng CN, Wu KH, Sheen JM, Chen SH, Lu MY, Hung GY, Yen HJ, Hsieh YL, Wang JL, Chang YH, Chang HH, Yeh TC, Weng TF, Hou JY, Chen BW, Chen RL, Wang LY, Ho WL, Chen YC, Cheng SN, Chao YH, Yang SH, Huang TH, Chou SW, Lin CY, Chen HY, Chao YY, Liang DC, Chang TT.
PMID: 33723338
Sci Rep. 2021 Mar 15;11(1):5893. doi: 10.1038/s41598-021-85321-3.

Improvement in outcomes of children with acute myeloid leukemia (AML) is attributed to several refinements in clinical management. We evaluated treatment outcomes of Taiwanese pediatric AML patients in the past 20 years. Overall, 860 de novo AML patients aged...

Cite
Yang YL, Jaing TH, Chen SH, et al. Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan. Sci Rep. 2021;11(1):5893doi: 10.1038/s41598-021-85321-3.
Yang, Y. L., Jaing, T. H., Chen, S. H., Liu, H. C., Hung, I. J., Lin, D. T., Yang, C. P., Peng, C. T., Lin, K. H., Hsiao, C. C., Jou, S. T., Chen, J. S., Lin, M. T., Wang, S. C., Chang, T. K., Huang, F. L., Cheng, C. N., Wu, K. H., Sheen, J. M., Chen, S. H., Lu, M. Y., Hung, G. Y., Yen, H. J., Hsieh, Y. L., Wang, J. L., Chang, Y. H., Chang, H. H., Yeh, T. C., Weng, T. F., Hou, J. Y., Chen, B. W., Chen, R. L., Wang, L. Y., Ho, W. L., Chen, Y. C., Cheng, S. N., Chao, Y. H., Yang, S. H., Huang, T. H., Chou, S. W., Lin, C. Y., Chen, H. Y., Chao, Y. Y., Liang, D. C., & Chang, T. T. (2021). Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan. Scientific reports, 11(1), 5893. https://doi.org/10.1038/s41598-021-85321-3
Yang, Yung-Li, et al. "Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan." Scientific reports vol. 11,1 (2021): 5893. doi: https://doi.org/10.1038/s41598-021-85321-3
Yang YL, Jaing TH, Chen SH, Liu HC, Hung IJ, Lin DT, Yang CP, Peng CT, Lin KH, Hsiao CC, Jou ST, Chen JS, Lin MT, Wang SC, Chang TK, Huang FL, Cheng CN, Wu KH, Sheen JM, Chen SH, Lu MY, Hung GY, Yen HJ, Hsieh YL, Wang JL, Chang YH, Chang HH, Yeh TC, Weng TF, Hou JY, Chen BW, Chen RL, Wang LY, Ho WL, Chen YC, Cheng SN, Chao YH, Yang SH, Huang TH, Chou SW, Lin CY, Chen HY, Chao YY, Liang DC, Chang TT. Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan. Sci Rep. 2021 Mar 15;11(1):5893. doi: 10.1038/s41598-021-85321-3. PMID: 33723338; PMCID: PMC7960737.
Copy Download .nbib Format: NLM
Biofilm Inhibition via Delivery of Novel Methylthioadenosine Nucleosidase Inhibitors from PVA-Tyramine Hydrogels while Supporting Mesenchymal Stromal Cell Viability.

ACS biomaterials science & engineering

Mutreja I, Warring SL, Lim KS, Swadi T, Clinch K, Mason JM, Sheen CR, Thompson DR, Ducati RG, Chambers ST, Evans GB, Gerth ML, Miller AG, Woodfield TBF.
PMID: 33405836
ACS Biomater Sci Eng. 2019 Feb 11;5(2):748-758. doi: 10.1021/acsbiomaterials.8b01141. Epub 2019 Jan 10.

The rise of antibiotic resistance, coupled with increased expectations for mobility in later life, is creating a need for biofilm inhibitors and delivery systems that will reduce surgical implant infection. A limitation of some of these existing delivery approaches...

Cite
Mutreja I, Warring SL, Lim KS, et al. Biofilm Inhibition via Delivery of Novel Methylthioadenosine Nucleosidase Inhibitors from PVA-Tyramine Hydrogels while Supporting Mesenchymal Stromal Cell Viability. ACS Biomater Sci Eng. 2019;5(2):748-758doi: 10.1021/acsbiomaterials.8b01141.
Mutreja, I., Warring, S. L., Lim, K. S., Swadi, T., Clinch, K., Mason, J. M., Sheen, C. R., Thompson, D. R., Ducati, R. G., Chambers, S. T., Evans, G. B., Gerth, M. L., Miller, A. G., & Woodfield, T. B. F. (2019). Biofilm Inhibition via Delivery of Novel Methylthioadenosine Nucleosidase Inhibitors from PVA-Tyramine Hydrogels while Supporting Mesenchymal Stromal Cell Viability. ACS biomaterials science & engineering, 5(2), 748-758. https://doi.org/10.1021/acsbiomaterials.8b01141
Mutreja, Isha, et al. "Biofilm Inhibition via Delivery of Novel Methylthioadenosine Nucleosidase Inhibitors from PVA-Tyramine Hydrogels while Supporting Mesenchymal Stromal Cell Viability." ACS biomaterials science & engineering vol. 5,2 (2019): 748-758. doi: https://doi.org/10.1021/acsbiomaterials.8b01141
Mutreja I, Warring SL, Lim KS, Swadi T, Clinch K, Mason JM, Sheen CR, Thompson DR, Ducati RG, Chambers ST, Evans GB, Gerth ML, Miller AG, Woodfield TBF. Biofilm Inhibition via Delivery of Novel Methylthioadenosine Nucleosidase Inhibitors from PVA-Tyramine Hydrogels while Supporting Mesenchymal Stromal Cell Viability. ACS Biomater Sci Eng. 2019 Feb 11;5(2):748-758. doi: 10.1021/acsbiomaterials.8b01141. Epub 2019 Jan 10. PMID: 33405836.
Copy Download .nbib Format: NLM
Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis.

Infection & chemotherapy

Oh HS, Kim JH, Woo ML, Kim JY, Park CH, Won H, Lim S, Jeong H, Ham SY, Kim EJ, Sheen S, Kang YM, Yoon D, Lee SY, Song KH.
PMID: 34951530
Infect Chemother. 2021 Nov 15; doi: 10.3947/ic.2021.0077. Epub 2021 Nov 15.

In preparation for the surge of coronavirus disease 2019 (COVID-19), it is crucial to allocate medical resources efficiently for distinguishing people who remain asymptomatic until the end of the disease. Between January 27, 2020, and April 21, 2020, 517...

Cite
Oh HS, Kim JH, Woo ML, et al. Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis. Infect Chemother. 2021;doi: 10.3947/ic.2021.0077.
Oh, H. S., Kim, J. H., Woo, M. L., Kim, J. Y., Park, C. H., Won, H., Lim, S., Jeong, H., Ham, S. Y., Kim, E. J., Sheen, S., Kang, Y. M., Yoon, D., Lee, S. Y., & Song, K. H. (2021). Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis. Infection & chemotherapy, . https://doi.org/10.3947/ic.2021.0077
Oh, Hong Sang, et al. "Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis." Infection & chemotherapy vol. (2021). doi: https://doi.org/10.3947/ic.2021.0077
Oh HS, Kim JH, Woo ML, Kim JY, Park CH, Won H, Lim S, Jeong H, Ham SY, Kim EJ, Sheen S, Kang YM, Yoon D, Lee SY, Song KH. Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis. Infect Chemother. 2021 Nov 15; doi: 10.3947/ic.2021.0077. Epub 2021 Nov 15. PMID: 34951530.
Copy Download .nbib Format: NLM
Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis.

Lipids in health and disease

Huang SW, Ou YC, Tang KS, Yu HR, Huang LT, Tain YL, Lin IC, Sheen JM, Hou CY, Tsai CC, Tiao MM.
PMID: 34496884
Lipids Health Dis. 2021 Sep 08;20(1):100. doi: 10.1186/s12944-021-01521-w.

BACKGROUND: The deleterious effect of maternal high-fat diet (HFD) on the fetal rat liver may cause later development of non-alcoholic fatty liver disease (NAFLD). The aim of this study was to evaluate the effect of maternal HFD-induced maternal hepatic...

Cite
Huang SW, Ou YC, Tang KS, et al. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis. Lipids Health Dis. 2021;20(1):100doi: 10.1186/s12944-021-01521-w.
Huang, S. W., Ou, Y. C., Tang, K. S., Yu, H. R., Huang, L. T., Tain, Y. L., Lin, I. C., Sheen, J. M., Hou, C. Y., Tsai, C. C., & Tiao, M. M. (2021). Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis. Lipids in health and disease, 20(1), 100. https://doi.org/10.1186/s12944-021-01521-w
Huang, Szu-Wei, et al. "Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis." Lipids in health and disease vol. 20,1 (2021): 100. doi: https://doi.org/10.1186/s12944-021-01521-w
Huang SW, Ou YC, Tang KS, Yu HR, Huang LT, Tain YL, Lin IC, Sheen JM, Hou CY, Tsai CC, Tiao MM. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis. Lipids Health Dis. 2021 Sep 08;20(1):100. doi: 10.1186/s12944-021-01521-w. PMID: 34496884; PMCID: PMC8424801.
Copy Download .nbib Format: NLM
Chirality-Dependent Anti-Inflammatory Effect of Glutathione after Spinal Cord Injury in an Animal Model.

Pharmaceuticals (Basel, Switzerland)

Kim SJ, Ko WK, Han GH, Lee D, Lee Y, Sheen SH, Hong JB, Sohn S.
PMID: 34451889
Pharmaceuticals (Basel). 2021 Aug 12;14(8). doi: 10.3390/ph14080792.

Neuroinflammation forms a glial scar following a spinal cord injury (SCI). The injured axon cannot regenerate across the scar, suggesting permanent paraplegia. Molecular chirality can show an entirely different bio-function by means of chiral-specific interaction. In this study, we...

Cite
Kim SJ, Ko WK, Han GH, et al. Chirality-Dependent Anti-Inflammatory Effect of Glutathione after Spinal Cord Injury in an Animal Model. Pharmaceuticals (Basel). 2021;14(8)doi: 10.3390/ph14080792.
Kim, S. J., Ko, W. K., Han, G. H., Lee, D., Lee, Y., Sheen, S. H., Hong, J. B., & Sohn, S. (2021). Chirality-Dependent Anti-Inflammatory Effect of Glutathione after Spinal Cord Injury in an Animal Model. Pharmaceuticals (Basel, Switzerland), 14(8), . https://doi.org/10.3390/ph14080792
Kim, Seong-Jun, et al. "Chirality-Dependent Anti-Inflammatory Effect of Glutathione after Spinal Cord Injury in an Animal Model." Pharmaceuticals (Basel, Switzerland) vol. 14,8 (2021). doi: https://doi.org/10.3390/ph14080792
Kim SJ, Ko WK, Han GH, Lee D, Lee Y, Sheen SH, Hong JB, Sohn S. Chirality-Dependent Anti-Inflammatory Effect of Glutathione after Spinal Cord Injury in an Animal Model. Pharmaceuticals (Basel). 2021 Aug 12;14(8). doi: 10.3390/ph14080792. PMID: 34451889; PMCID: PMC8398565.
Copy Download .nbib Format: NLM
Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro.

Pharmaceutics

Lee D, Ko WK, Kim SJ, Han IB, Hong JB, Sheen SH, Sohn S.
PMID: 33805431
Pharmaceutics. 2021 Mar 29;13(4). doi: 10.3390/pharmaceutics13040462.

Gold nanoparticles (GNPs) have been widely studied to inhibit differentiation into osteoclasts. However, reports of the inhibitory effects of silver nanoparticles (SNPs) during the process of differentiation into osteoclasts are rare. We compared the inhibitory effect of GNPs and...

Cite
Lee D, Ko WK, Kim SJ, et al. Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro. Pharmaceutics. 2021;13(4)doi: 10.3390/pharmaceutics13040462.
Lee, D., Ko, W. K., Kim, S. J., Han, I. B., Hong, J. B., Sheen, S. H., & Sohn, S. (2021). Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro. Pharmaceutics, 13(4), . https://doi.org/10.3390/pharmaceutics13040462
Lee, Daye, et al. "Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro." Pharmaceutics vol. 13,4 (2021). doi: https://doi.org/10.3390/pharmaceutics13040462
Lee D, Ko WK, Kim SJ, Han IB, Hong JB, Sheen SH, Sohn S. Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro. Pharmaceutics. 2021 Mar 29;13(4). doi: 10.3390/pharmaceutics13040462. PMID: 33805431; PMCID: PMC8065415.
Copy Download .nbib Format: NLM
Correction: Increased non-typhoidal Salmonella hospitalizations in transfusion-naïve thalassemia children: a nationwide population-based cohort study.

Pediatric research

Sheen JM, Lin FJ, Yang YH, Kuo KC.
PMID: 34480087
Pediatr Res. 2021 Sep 03; doi: 10.1038/s41390-021-01662-9. Epub 2021 Sep 03.

No abstract available.

Cite
Sheen JM, Lin FJ, Yang YH, et al. Correction: Increased non-typhoidal Salmonella hospitalizations in transfusion-naïve thalassemia children: a nationwide population-based cohort study. Pediatr Res. 2021;doi: 10.1038/s41390-021-01662-9.
Sheen, J. M., Lin, F. J., Yang, Y. H., & Kuo, K. C. (2021). Correction: Increased non-typhoidal Salmonella hospitalizations in transfusion-naïve thalassemia children: a nationwide population-based cohort study. Pediatric research, . https://doi.org/10.1038/s41390-021-01662-9
Sheen, Jiunn-Ming, et al. "Correction: Increased non-typhoidal Salmonella hospitalizations in transfusion-naïve thalassemia children: a nationwide population-based cohort study." Pediatric research vol. (2021). doi: https://doi.org/10.1038/s41390-021-01662-9
Sheen JM, Lin FJ, Yang YH, Kuo KC. Correction: Increased non-typhoidal Salmonella hospitalizations in transfusion-naïve thalassemia children: a nationwide population-based cohort study. Pediatr Res. 2021 Sep 03; doi: 10.1038/s41390-021-01662-9. Epub 2021 Sep 03. PMID: 34480087.
Copy Download .nbib Format: NLM
Hospital Safety-Net Burden and Risk for Readmissions and Severe Maternal Morbidity.

American journal of perinatology

McKinley LP, Wen T, Gyamfi-Bannerman C, Wright JD, Goffman D, Sheen JJ, D'Alton ME, Friedman AM.
PMID: 32369860
Am J Perinatol. 2021 Aug;38:e359-e366. doi: 10.1055/s-0040-1710544. Epub 2020 May 05.

OBJECTIVE: This study aimed to analyze whether hospital safety-net burden status is associated with increased risk for severe maternal morbidity (SMM) and postpartum readmissions.STUDY DESIGN: The 2010 to 2014 Nationwide Readmissions Database was utilized for this retrospective cohort study....

Cite
McKinley LP, Wen T, Gyamfi-Bannerman C, et al. Hospital Safety-Net Burden and Risk for Readmissions and Severe Maternal Morbidity. Am J Perinatol. 2020;38:e359-e366doi: 10.1055/s-0040-1710544.
McKinley, L. P., Wen, T., Gyamfi-Bannerman, C., Wright, J. D., Goffman, D., Sheen, J. J., D'Alton, M. E., & Friedman, A. M. (2021). Hospital Safety-Net Burden and Risk for Readmissions and Severe Maternal Morbidity. American journal of perinatology, 38e359-e366. https://doi.org/10.1055/s-0040-1710544
McKinley, Lilian P, et al. "Hospital Safety-Net Burden and Risk for Readmissions and Severe Maternal Morbidity." American journal of perinatology vol. 38 (2021): e359-e366. doi: https://doi.org/10.1055/s-0040-1710544
McKinley LP, Wen T, Gyamfi-Bannerman C, Wright JD, Goffman D, Sheen JJ, D'Alton ME, Friedman AM. Hospital Safety-Net Burden and Risk for Readmissions and Severe Maternal Morbidity. Am J Perinatol. 2021 Aug;38:e359-e366. doi: 10.1055/s-0040-1710544. Epub 2020 May 05. PMID: 32369860.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 224 entries